What hormone levels should be checked in a male infant with micropenis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hormonal Evaluation in Male Infants with Micropenis

In a male infant with micropenis, you must immediately check serum testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) to distinguish between hypogonadotropic hypogonadism (hypothalamic/pituitary failure) and hypergonadotropic hypogonadism (testicular failure), as this determines both prognosis and treatment approach. 1, 2

Initial Hormonal Assessment

The core hormonal panel should include:

  • Serum testosterone: Essential to document testosterone deficiency, which is the most common cause of micropenis 3, 1
  • Luteinizing hormone (LH): Distinguishes central (low/normal LH) from primary testicular failure (elevated LH) 4, 1
  • Follicle-stimulating hormone (FSH): Helps assess testicular function and Sertoli cell integrity 4, 1

The optimal timing for this evaluation is during the "mini-puberty" period (first 2-3 months of life) when gonadotropins and testosterone are physiologically elevated, making interpretation more reliable. 2

Additional Hormonal Testing Based on Initial Results

If LH and FSH are Low or Low-Normal with Low Testosterone:

  • Serum prolactin: Must be measured to screen for hyperprolactinemia, which can indicate pituitary pathology such as prolactinomas 4
  • Growth hormone assessment: Growth velocity should be monitored, as associated hypothalamic or pituitary pathology is common in hypogonadotropic hypogonadism 1
  • Consider pituitary MRI: If testosterone is severely low (<150 ng/dL equivalent for age) with low/normal LH, imaging may identify non-secreting adenomas or structural abnormalities 4

If LH and FSH are Elevated with Low Testosterone:

This indicates primary testicular failure (hypergonadotropic hypogonadism). Consider:

  • Karyotype analysis: To evaluate for chromosomal abnormalities, particularly if bilateral testicular abnormalities are present 4, 1
  • Anti-Müllerian hormone (AMH): May help assess Sertoli cell function in cases of suspected testicular dysgenesis 5

Critical Situations Requiring Immediate Specialist Consultation

If bilateral nonpalpable testes are present with micropenis, this is a medical emergency requiring immediate endocrinology consultation to rule out congenital adrenal hyperplasia (CAH) in a 46,XX individual with severe virilization. 4, 6 A phenotypic male newborn with bilateral nonpalpable testes could be a genetic female with life-threatening CAH that can cause shock, hyponatremia, and hyperkalemia if undiagnosed. 4, 6

In this scenario, additional urgent testing includes:

  • 17-hydroxyprogesterone: To screen for CAH 4
  • Serum electrolytes: To detect life-threatening electrolyte abnormalities 4
  • Karyotype: To determine genetic sex 4

Functional Testing

GnRH stimulation test and/or hCG stimulation test: These are often helpful in evaluating the etiology when baseline hormones are equivocal, particularly to assess the capacity of the hypothalamic-pituitary-gonadal axis to respond 1, 2, 7

The hCG stimulation test specifically evaluates Leydig cell function and the penis's ability to respond to testosterone, which is prognostically important. 1, 7

Common Pitfalls to Avoid

  • Do not delay hormonal evaluation: The mini-puberty window (first 2-3 months) provides the most reliable hormonal assessment; after this period, gonadotropins and testosterone naturally decline, making interpretation difficult 2
  • Do not assume idiopathic micropenis without complete evaluation: Many cases have identifiable endocrine causes that require specific treatment 1, 2
  • Do not order imaging before hormonal assessment: Ultrasound or other imaging of the genitalia rarely assists in decision-making and should not delay hormonal evaluation 4, 6
  • Do not circumcise the infant until evaluation is complete: Particularly if bilateral nonpalpable testes are present, as this may represent a disorder of sex development 4

Algorithmic Approach

  1. Measure stretched penile length using standard technique and compare to age-specific nomograms (micropenis = <2.5 SD below mean) 1, 2

  2. Examine for testicular position: Palpable vs. nonpalpable, bilateral vs. unilateral 4, 1

  3. If bilateral nonpalpable testes: Emergency endocrinology referral, check 17-hydroxyprogesterone, electrolytes, and karyotype immediately 4, 6

  4. If testes palpable or unilateral nonpalpable: Check testosterone, LH, FSH during mini-puberty (ideally 2-3 months of age) 1, 2

  5. Based on LH/FSH results:

    • Low/normal LH+FSH → Check prolactin, assess growth, consider pituitary pathology 4, 1
    • Elevated LH+FSH → Consider karyotype, evaluate for testicular failure 4, 1
  6. Consider functional testing (GnRH or hCG stimulation) if baseline results are equivocal 1, 7

  7. Initiate testosterone trial (25-50 mg testosterone enanthate intramuscularly) to assess penile response, regardless of etiology 3, 1, 2, 8

References

Research

The child with micropenis.

Indian journal of pediatrics, 2000

Research

[Micropenis].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Constitutional Small Testes (Microorchidism)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Surgical Intervention Timing for Undescended Testis (Cryptorchidism)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Micropenis. Results of treatment with testosterone].

Archives francaises de pediatrie, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.